MCAP logo

MedCap AB (publ) Stock Price

OM:MCAP Community·SEK 8.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 8 Fair Values set on narratives written by author

MCAP Share Price Performance

SEK 593.00
109.50 (22.65%)
SEK 593.00
109.50 (22.65%)
Price SEK 593.00

MCAP Community Narratives

There are no narratives available yet.

Recent MCAP News & Updates

Is MedCap (STO:MCAP) Using Too Much Debt?

Sep 25
Is MedCap (STO:MCAP) Using Too Much Debt?

A Look At The Intrinsic Value Of MedCap AB (publ) (STO:MCAP)

Aug 28
A Look At The Intrinsic Value Of MedCap AB (publ) (STO:MCAP)

MedCap AB (publ)'s (STO:MCAP) Shares Climb 27% But Its Business Is Yet to Catch Up

Jul 13
MedCap AB (publ)'s (STO:MCAP) Shares Climb 27% But Its Business Is Yet to Catch Up

MedCap (STO:MCAP) Strong Profits May Be Masking Some Underlying Issues

May 07
MedCap (STO:MCAP) Strong Profits May Be Masking Some Underlying Issues

Subdued Growth No Barrier To MedCap AB (publ) (STO:MCAP) With Shares Advancing 28%

May 04
Subdued Growth No Barrier To MedCap AB (publ) (STO:MCAP) With Shares Advancing 28%

MedCap AB (publ) Key Details

SEK 1.9b

Revenue

SEK 796.3m

Cost of Revenue

SEK 1.1b

Gross Profit

SEK 908.5m

Other Expenses

SEK 198.6m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 24, 2025
Earnings per share (EPS)
13.20
Gross Margin
58.16%
Net Profit Margin
10.43%
Debt/Equity Ratio
4.4%

MedCap AB (publ) Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet and slightly overvalued.

0 Risks
2 Rewards

About MCAP

Founded
2001
Employees
583
CEO
Anders Dahlberg
WebsiteView website
medcap.se/en/

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, pharmaceuticals, med tech and assistive tech companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Nordic region and Northern Europe. It typically invests between SEK25 million ($2.75 million) and SEK150 million ($16.51 million) with enterprise value SEK50 million ($5.90 million) and SEK250 million ($23.06 million) and sales revenue between €5 million ($5.43 million) and €25 million ($27.18 million) and EBITDA between SEK1 million ($0.11 million) and SEK50 million ($5.50 million). The firm takes minority and majority stake. It uses its capital and loans and makes balance sheet investments. MedCap AB (publ) was founded in 2001 and is based in Stockholm, Sweden.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Swedish Market Performance

  • 7 Days: 1.7%
  • 3 Months: 2.4%
  • 1 Year: -0.5%
  • Year to Date: 2.9%
The market has climbed 1.7% in the last 7 days, lead by the Industrials sector with a gain of 2.6%. As for last year, the market performance has been flat. Looking forward, earnings are forecast to grow by 16% annually. Market details ›